UROVANT SCIENCES LTD's ticker is UROV and the CUSIP is G9381B108. A total of 41 filers reported holding UROVANT SCIENCES LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,096,000 | – | 191,933 | – | 1.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 157,480 | $1,246,000 | 0.82% |
| Prosight Management, LP | 142,620 | $1,128,000 | 0.57% |
| Sio Capital Management, LLC | 220,042 | $1,741,000 | 0.42% |
| Perceptive Advisors | 1,875,426 | $14,835,000 | 0.34% |
| Park West Asset Management LLC | 432,500 | $3,421,000 | 0.14% |
| Eventide Asset Management | 401,558 | $3,176,000 | 0.10% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $7,910,000 | 0.02% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 51,100 | $404,000 | 0.01% |
| Weiss Multi-Strategy Advisers LLC | 25,000 | $198,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 438,911 | $3,472,000 | 0.01% |